Login    Join free Add to favorites    中文
Home > News > Merck Opens Application Phase for Next Accelerator
Industry Updates New Products Supplier News Upcoming Events business web
Merck Opens Application Phase for Next Accelerator
hits:65     Date:06/06/19

Merck today announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program.
 
  • Startups can apply for programs at Merck headquarters in Darmstadt or in China
  • Focus is on four fields: biosensing & interfaces, liquid biopsy technologies, clean meat, and artificial intelligence (AI)-enabled health solutions
 
Merck, a leading science and technology company, today announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups can choose to participate in one of the two programs, either at the company鈥檚 Innovation Center at global headquarters in Darmstadt or at its China Innovation Hub in Shanghai.
 
鈥淲e generate new business by driving innovation beyond what we are currently doing,鈥 said Isabel De Paoli, Chief Strategy Officer at Merck. 鈥淐ollaborating with startups around the globe via the Merck Accelerator offers the exciting opportunity to create a win-win situation for both the startups and Merck. They gain access to a strong partner with a lot of experience in partnerships that helps them to accelerate their industry-ready business, whereas we obtain fresh stimulus to drive innovation beyond our current activities. Joining forces can create an impact in tackling the challenges of humanity.鈥

The Merck Accelerator with programs in Germany and in China connects startups to innovation projects of Merck and its three business sectors for co-development and sustainable business partnerships. During a three-month period, startups receive financial support of up to 鈧 50,000 and benefit from in-depth coaching from a global network of over 50,000 experts, as well as mentoring from Merck senior management, coaching sessions and visibility by attending inspirational and renowned events in the startup ecosystem.

In Darmstadt, the chosen startups will have access to the modern workspace at the futuristic Merck Innovation Center with prototyping facilities in the Makerspace. In China, startups will have access to the local Merck network and mixed sites such as Guangzhou, Beijing and Shanghai with different business focus and ecosystems.

Besides the core areas of Merck research in Healthcare, Life Science and Performance Materials, the main focus of the Merck Accelerator is to partner with startups in the company鈥檚 innovation fields:
 
  • Biosensing & Interfaces: technologies to interface between the biological and digital world
  • Liquid Biopsy Technologies: solutions to overcome challenges in the liquid biopsy workflow
  • Clean Meat: enabling technology required to produce clean meat (specifically for the headquarters program at the Innovation Center)
  • AI-enabled health solutions that include AI solutions for diagnosis rate improvement and precision medicine; AI-enabled drug R&D; Digital therapeutics (specifically for the program in China)
 
鈥淲e have a lot of experience in partnering with startups. To make collaboration happen, we ensure startups the right connections within Merck,鈥 said Michael Gamber, Head of Merck Innovation Center. 鈥淭he last intake of the Merck Accelerator at the Innovation Center was incredibly successful and 90% of the startups are either collaborating or in negotiations to partner with us.鈥

For example, iXensor, a startup alumni that recently completed from the Merck Accelerator program at the Innovation Center in April, is one of the startups that reached a collaboration with Merck to gain initial access to the African market. The Taiwanese startup conducted a first successful pilot test at Merck CURAFATM points of care in Kenya and provided its latest technology devices to support an initiative that seeks to improve primary healthcare access for the local underserved population in emerging economies.

So far, 57 startups have already participated in the Merck Accelerator program since the first intake in 2015. Merck is currently looking for up to 12 startups to participate in the program in Darmstadt and up to six startups for its China Innovation Hub.
 
The Accelerator programs will simultaneously take place from mid-January to April 2020 at the Merck Innovation Center in Darmstadt and at the China Innovation Hub. Right after each program, selected startups will also have the opportunity to extend their stay either in China or in Darmstadt. Applications for both programs are open from now until August 25, 2019.
 
For more information, please visit this website.
 
About the Merck Innovation Center
Complementing research and development in the company鈥檚 business sectors, the Merck Innovation Center supports the scaling of new businesses beyond the company鈥檚 current scope. With its initiatives, creative working environment and culture of openness and exchange, the Innovation Center connects employees, startups and companies to create groundbreaking innovations.
 
About the China Innovation Hub
As part of the Merck global innovation network, the China Innovation Hub scouts, incubates and invests in innovative opportunities in Merck鈥榮 current businesses and in fields between and beyond these. The China Innovation Hub is committed to partnering with start-ups, academic institutions, industry players and local governments. By combining unique technology and expertise from the Merck Group and collaborators, the aim is to develop novel technologies and bring new solutions to the market for China and the rest of the world. The China Innovation Hub also provides support of ideation, incubation and training to local talent, partners and Merck employees to build win-win collaborations.
 
About Merck
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people鈥檚 lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices 鈥 the company is everywhere. In 2018, Merck generated sales of 鈧 14.8 billion in 66 countries.
 
Scientific exploration and responsible entrepreneurship have been key to Merck鈥檚 technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
Merck KGaA
Tel锛+49 (0) 6151 72-0
E-mail锛service@merckgroup.com
Related News>> more
advertisement
Copyright(C) 2006-2019 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙